# A Liquid Biopsy for Pancreatic Cancer Early-detection and Disease Monitoring

> **NCT07700992** · — · RECRUITING · sponsor: **Università Vita-Salute San Raffaele** · enrollment: 600 (estimated)

## Conditions studied

- Familial Pancreatic Cancer
- Familial Pancreatic Carcinoma
- Hereditary Pancreatic Cancer
- Hereditary Pancreatitis
- Pancreas Cancer
- Pancreas Neoplasm
- Pancreas Adenocarcinoma
- Pancreas Cyst
- Pancreatic Neoplasms
- Intraductal Papillary Mucinous Neoplasm

## Interventions

- **DIAGNOSTIC_TEST:** PANXEON

## Key facts

- **NCT ID:** NCT07700992
- **Lead sponsor:** Università Vita-Salute San Raffaele
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2026-06-03
- **Primary completion:** 2031-12-31
- **Final completion:** 2032-01-30
- **Target enrollment:** 600 (ESTIMATED)
- **Last updated:** 2026-07-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07700992

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07700992, "A Liquid Biopsy for Pancreatic Cancer Early-detection and Disease Monitoring". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07700992. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
